Sirard Cynthia 4
4 · Compass Therapeutics, Inc. · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Sirard Cynthia
Chief Medical Officer
Transactions
- Award
STOCK OPTION (RIGHT TO BUY)
2026-01-02+1,000,000→ 1,000,000 totalExercise: $5.17Exp: 2036-01-02→ COMMON STOCK (1,000,000 underlying)
Footnotes (2)
- [F1]The options were granted pursuant to the Compass Therapeutics, Inc. 2025 Inducement Plan as a material inducement to the Reporting Person's acceptance of employment with the Issuer in accordance with Nasdaq Rule 5635(c)(4).
- [F2]The options will vest over four years, as follows: 25% of the shares underlying the option will vest and become exercisable on January 2, 2027, with the remaining 75% vesting in 36 substantially equal monthly installments thereafter.